Conference agenda

Programme for the Anglonordic Biotech Conference IX, 2012

23 May

Kick-off! The conference starts with a reception at the Residence of the Swedish Ambassador in London the evening before the event. The reception starts at 18.30 and ends 20.00.
Please note that there is a separate registration for the reception and a limited number of 150 participants at the Residence (registration closes when fully booked).

(Please note that there is a separate registration for the drink reception)

24 May

09.00 – 09.40	Registration at 1VS Westminster Conference Centre, 1 Victoria Street, London, SW1
09.40 – 09.50	Welcome Remarks from the Conference Chairman – Ole Jørgen Marvik, Sector Head, Health and Life Sciences, Innovation Norway
09.50 – 10.30	Partnering pitches ProtAffin - www.protaffin.com Creative Antibiotics - www.creativeantibiotics.com EpiTherapeutics - www.epitherapeutics.dk
10.30 – 11.00	Topic to be confirmed – Rob Pinnock, Director, External Scientific Affairs & Alliance Management UK, Ireland, Portugal & Spain, Worldwide Licensing, MSD
11.00 – 11.30	BIOTECHNOLOGY: The Challenges of the Future - Keynote speaker – Baroness Susan Greenfield
11.30 – 12.00	What is the evidence that rationale selection of patients is improving patient outcomes – Nexus Oncology, Clare Wareing, Founder and CSO
12.00 – 13.20	LUNCH - sponsored by Ezenze
13.20 – 14.05	If I Knew Then What I Know Today (Panel) Moderator: Mike Ward, Editor-in-Chief, Scrip Intelligence Panel: - Sir Greg Winter - Leif Helth Jensen, Investment Manager, CAT Management - Tom Pike, Chairman/Director, Vaccibody AS, Clanotech AB, Diagenic ASA and others
14.05 – 14.55	Partnering pitches F-star - www.f-star.com Orexo - www.orexo.com Novozymes Biopharma - www.biopharma.novozymes.com Xention - www.xention.com
14.55 – 15.25	The value and scope of biotech patents - the misconceptions and the reality - Elizabeth Jones, Partner, Dehns
15.25 – 15.45	Partnership and collaborations in translational research: New models from the UK - Matthew Hallsworth, Head of External Relations, NIHR Office for Clinical Research Infrastructure
15.45 – 16.00	Translational research and clinical trials in Denmark:Excellence in early drug development - Lars Arendt-Nielsen, Director of R&D, C4Pain & Head of Centre and Professor, Aalborg University
16.00 – 16.30	Latest News on European Funding – Dinko Valerio, Partner and Co-founder, Aescap Venture
16.30 – 16.45	Conclusions and Q&A
16.45 – 18.30	Afternoon Buffet and Drinks - sponsored by Enzenze